MedTrace Logo

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

NCT03683680 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2026-05-05

No results posted yet for this study

Summary

This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.

Conditions

Interventions

OTHER

MPT Test

molecular expression tests at the RNA level using approximately 7 or more genes with RTPCR, nanostring or similar platforms

OTHER

CLDN15/VIM Test

molecular expression tests at the RNA level using approximately 7 or more genes with RTPCR, nanostring or similar platforms

Sponsors & Collaborators

Principal Investigators

  • Raphael Bueno, MD · Brigham and Women's Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-31
Primary Completion
2030-01-01
Completion
2030-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03683680 on ClinicalTrials.gov